ClinicalTrials.gg
CompletedNCT06124170Updated Nov 9, 2023

Improved Pain Management in Knee Osteoarthritis-related Surgeries

An observational study in Knee Osteoarthritis, Total Knee Arthroplasty and Unicompartmental Knee Arthroplasty, sponsored by Peng Liu. Completed at 1 site in China. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-11-09.

Sponsored by Peng Liu · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
714
Ages
50 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 136 studies in Osteoarthritis, Knee with a site in China — 32 open to participants now, 32 under way, 4 of them phase 3. Osteoarthritis, Knee · China.

Enrollment
3rd of 21
714 · median 136
Started
2016
with 10 others
Observational
21 of 136
5 open now
Registered
98th of 136
by date

Among the 136 studies in Osteoarthritis, Knee with a site in China, this one is the 3rd largest by enrollment of the 21 observational ones that give a count, is one of 11 that started in 2016, is one of 21 observational ones, and was the 98th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

32 of the 136 studies in Osteoarthritis, Knee with a site in China are open now. Recruiting first, the newest first:

27 more — sign in →

All 32 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 50 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 136 studies in Osteoarthritis, Knee with a site in China, or all of them as a file.
02

Study summary

In recent years, pain management coordinated with enhanced recovery after surgery (ERAS) has been widely applied and rapidly developed in orthopedics, showing promising prospects. Since 2016, our hospital has used a series of continuously improved pain management schemes for patients with knee OA who underwent total knee arthroplasty (TKA), unicompartmental knee arthroplasty (UKA), and high tibial osteotomy (HTO). Here, we retrospectively analyze these patients' clinical data to compare the effects of different pain intervention measures during the perioperative period on postoperative pain, functional exercise, hospital stay, and prognosis of the three surgical methods in an attempt to provide a feasible solution for pain management of these patients.

Read the detailed description

We retrospectively analyzed the clinical data of patients with knee osteoarthritis (OA) who received surgical treatment to provide a feasible solution for perioperative pain management of these patients. The medical records of 714 patients with knee OA who had undergone total knee arthroplasty (n=551), unicompartmental knee arthroplasty (n=92) and high tibial osteotomy (n=71) were retrospectively analyzed and the cases were divided into Groups A, B, and C, according to the continuously optimized pain management. Clinical data including anesthesia grade, surgery time, functional exercise, hospital stay, pain, emotion, complications and prognosis were compared.

03

Conditions studied

  • Knee Osteoarthritis
  • Total Knee Arthroplasty
  • Unicompartmental Knee Arthroplasty
  • High Tibial Osteotomy
  • Pain Management
04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The medical records of 714 patients (142 men, 40 women; mean age: 38.5 years; age range: 18-64 years) with moderate or severe knee OA who had undergone TKA (n=551), UKA (n=92), or HTO (n=71) in a group of joint surgery at Sichuan Provincial People's Hospital between March 2016 and February 2022 were retrospectively analyzed. Clinical data, including age, weight, height, anesthesia grade, surgery, and time, as well as continuously improved perioperative pain management measures, were recorded.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • first knee surgery were 50-80 years old had complete clinical and follow-up data

Exclusion criteria

Exclusion Criteria:

  • Physical Status grade≥4 comorbidity with three or more systemic diseases long-term anxiety and depression, of painkillers, long-term alcoholism, or taking painkillers concomitant limb pain caused by spinal degeneration
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
714 participants (actual)
Patient registry
No

Groups and cohorts

  • Total knee arthroplasty (TKA)

    Total knee arthroplasty

    Procedure: Preoperative pain managment · Procedure: Intraoperative pain managment · Procedure: Postoperative pain managment

  • Unicompartmental knee arthroplasty (UKA)

    Unicompartmental knee arthroplasty

    Procedure: Preoperative pain managment · Procedure: Intraoperative pain managment · Procedure: Postoperative pain managment

  • High tibial osteotomy (HTO)

    High tibial osteotomy

    Procedure: Preoperative pain managment · Procedure: Intraoperative pain managment · Procedure: Postoperative pain managment

Interventions

  • ProcedurePreoperative pain managment

    propaganda and education on pain; Preemptive analgesia with celecoxib (200 mg bid) 2 days before surgery

  • ProcedureIntraoperative pain managment

    Squeeze to expel blood (tourniquet); Before skin suture, 20 mL 0.5% ropivacaine was given subcutaneously for local infiltration anesthesia;

  • ProcedurePostoperative pain managment

    The intravenous analgesia pump was placed until 48 h after surgery;On the second day after surgery, celecoxib (200 mg bid) was administered orally, and buprenorphine transdermal patch was applied externally until hospital discharge;FNB catheter was placed under the guidance of ultrasound and connected with an analgesic pump, the anesthesia lasted until 48 h after surgery ‡

06

What researchers measure

Primary outcomes

  1. visual analogue score (VAS)

    visual analogue score (VAS)

    Time frame: 24 hours after surgery

  2. visual analogue score (VAS)

    visual analogue score (VAS)

    Time frame: 72 hours after surgery

Secondary outcomes

  1. Quadriceps muscle strength

    Quadriceps muscle strength

    Time frame: 24 hours after surgery

  2. Quadriceps muscle strength

    Quadriceps muscle strength

    Time frame: 72 hours after surgery

  3. Scope of activities to knee joint

    Scope of activities to knee joint

    Time frame: 24 hours after surgery

  4. Scope of activities to knee joint

    Scope of activities to knee joint

    Time frame: 72 hours after surgery

Other outcomes

  1. Self-Rating Anxiety Scale (SAS)

    Self-Rating Anxiety Scale (SAS)

    Time frame: 24 hours after surgery

  2. Self-Rating Anxiety Scale (SAS)

    Self-Rating Anxiety Scale (SAS)

    Time frame: 72 hours after surgery

  3. Self-Rating Depression Scale (SDS)

    Self-Rating Depression Scale (SDS)

    Time frame: 24 hours after surgery

  4. Self-Rating Depression Scale (SDS)

    Self-Rating Depression Scale (SDS)

    Time frame: 72 hours after surgery

07

Study locations

1 site
  • Sichuan Provincial People's Hospital
    Chengdu, Sichuan 610072, China
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2016 to primary completion in Mar 2022, 72 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2023
First posted
Nov 9, 2023
StartActual
Mar 1, 2016
Primary completionActual
Mar 2, 2022
CompletionActual
Mar 2, 2023
Last update
Nov 9, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 9, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06124170
Lead sponsor
Peng Liu
Responsible party
Peng Liu (Professor, Sichuan Provincial People's Hospital) — Sponsor-investigator
First posted
Nov 9, 2023
Start date
Mar 1, 2016
Primary completion
Mar 2, 2022
Completion
Mar 2, 2023
Last update
Nov 9, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion